NLR inflammasome pathways: key targets for pathogenesis and therapy of metabolic diseases - Poll - MDSpire

NLR inflammasome pathways: key targets for pathogenesis and therapy of metabolic diseases

  • By

  • Jun Zhou

  • Ruohao Yang

  • Wanyu Zhu

  • Zhilin He

  • Yueke Ma

  • Zhiwei Feng

  • Lili Yu

  • May 29, 2026

  • 0 min

Share

Original Source(s)

NLR inflammasome pathways: key targets for pathogenesis and therapy of metabolic diseases

  • by Jun Zhou, Ruohao Yang, Wanyu Zhu, Zhilin He, Yueke Ma, Zhiwei Feng, Lili Yu

  • May 29, 2026

Related Content

The relationships between fat-soluble vitamin deficiency and childhood obesity risk

Optimal Dietary Patterns for Lower Weight Gain and Risk of Obesity Surrounding Menopause

Grip Strength Plus Waist Size May Flag Risk T2D Risk

Researchers found that patients with higher waist circumference and lower grip strength had the greatest risk for developing type 2 diabetes during long-term follow-up.